Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Humanised Fc engineered monoclonal antibody against CD19

EU orphan designation number: EU/3/14/1286   
Active ingredient: Humanised Fc engineered monoclonal antibody against CD19
Indication: Treatment of chronic lymphocytic leukaemia / small lymphocytic lymphoma
Sponsor: MorphoSys AG
Semmelweisstr. 7, 82152 Planegg, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/07/2014 Orphan designation EMA/OD/022/14 (2014)4841 of 04/07/2014
24/01/2017 Change of name and/or address of sponsor